What drove PBH's consistent earnings beats in 2025?

Prestige Consumer Healthcare Inc. (PBH) has demonstrated consistent earnings beats in 2025, driven by several key factors: 1. **Revenue Growth**: The company's revenue grew by 2.68% year-over-year to $290.32 million in Q3 2025. This increase was driven by strong performance in its international business and improvements in sales from its Clear Eyes brand. 2. **Net Income Growth**: Prestige Consumer Healthcare reported a net income of $61.03 million in Q3 2025, representing a 15.05% year-over-year growth. This growth in net income reflects the company's ability to generate profits from its operations. 3. **Diluted EPS Growth**: The diluted EPS increased by 15.09% to $1.22 in Q3 2025 compared to the same period in the previous year. This indicates that not only has the company increased its net income, but it has also improved the efficiency of its operations, as evidenced by the higher earnings per share. 4. **Market Presence and Demand**: The company's steady performance highlights the robust demand and market presence of Prestige's GI products. This strong market presence has allowed the company to maintain its sales momentum and profitability. 5. **Strategic Initiatives**: Prestige Consumer Healthcare has implemented strategic initiatives such as debt reduction initiatives, which have contributed to the company's financial strength and ability to generate earnings. In conclusion, Prestige Consumer Healthcare's consistent earnings beats in 2025 can be attributed to a combination of revenue growth, net income growth, diluted EPS growth, strong market presence, and strategic initiatives. These factors have collectively driven the company's financial performance and earnings beats in the period.